Today on LabTechnologist.com   · Bio-Rad tackles the 'SELDI biomarker controversy' · ABI launches new miRNA expression arrays · Codexis expands portfolio with BioCatalytics buyout · How flow rate can affect microfluidic cellular assays · Industry news in brief - week 30

Other top industry news   · The future of oral controlled release · Tamiflu caps for kids get EU thumbs up · Innovative drugs highlighted at AIDS expo · FDA studies outside US minimal, survey reveals

	Laboratory Equipment
Search Forward to a colleague		Tuesday 24 July 2007

	Product Overview A revolution in Sales Lead Generation - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now! Click Here Access full stories Bio-Rad tackles the 'SELDI biomarker controversy' Ever since Bio-Rad's acquisition of Ciphergen's SELDI MS (surface enhanced laser desorption/ionisation mass spectrometry) technology late last year, it has been fighting against the spectre of "controversial" research... Read ABI launches new miRNA expression arrays Applied Biosystems (ABI) has launched its TaqMan microRNA (miRNA) assays in array format to help researchers search for miRNA biomarkers more efficiently from smaller samples... Read Codexis expands portfolio with BioCatalytics buyout Biocatalysis expert Codexis has acquired BioCatalytics for an undisclosed amount to strengthen its off-the-shelf biocatalyst portfolio and give itself a larger 'window to the market'... Read How flow rate can affect microfluidic cellular assays UK researchers have shown that high fluid flow rates in microfluidic devices used for cellular assays can affect cell signalling channels and potentially interfere with drug screening results... Read Industry news in brief - week 30 LabTechnologist.com brings you its periodic round-up of industry news, including new developments at Affymetrix, Bio-Rad, Jeol, Illumina, NuGen, Qiagen, Roche and VWR... Read
	All News Headlines for: July | June | May
	Sponsored Message Elix® systems: a 4-step purification process Millipore™'s Elix systems combine pretreatment, advanced reverse osmosis, electrodeionization, and bacterial reduction with an integrated 254 nm UV lamp to produce consistently-pure Type II water from potable tap water. Click Here

Product Innovation Alerts Indicate your research interests and receive alerts on relevant products and market innovations - Free of charge Analysis and instrumentation Chemicals & Consumables General lab equipment IT Liquid handling and automation Separation and purification News Product Categories > Analysis and instrumentation > Chemicals & Consumables > General lab equipment > IT > Liquid handling and automation > Separation and purification Related Web Sites > OutSourcing-Pharma.com > FoodNavigator.com > CosmeticsDesign-Europe.com > All our Websites

Other top industry news The future of oral controlled release The field of oral controlled release drug delivery is constantly evolving and developing, allowing ever more precise and tailored delivery profiles for pharmaceutical drugs.  In-PharmaTechnologist.com caught... Read Tamiflu caps for kids get EU thumbs up Roche has received a positive opinion from EU regulators recommending the approval of low-dose capsules of the blockbuster flu drug Tamiflu (oseltamivir), providing a more convenient dosage form for children... Read Innovative drugs highlighted at AIDS expo As scientists continually strive to develop new ways to tackle the HIV/AIDS pandemic, several new drugs and their targets were highlighted at the ongoing International Aids Society (IAS) Conference... Read FDA studies outside US minimal, survey reveals Despite the hype, countries in emerging markets are still very much trailing behind the US in the number of Food and Drug Administration (FDA)-approved studies being conducted, particularly the Asia-pacific, a... Read Weekly Comment Informed consent 'not up to scratch' A recent survey of clinical trial participants in the US has revealed worrying signs that the informed consent process is 'not up to scratch'. Read Sponsored Message Live cell-based assay with Bionas® 2500 analyzing system Bionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds. Click Here Previous Headlines Carl Zeiss ships first helium ion microscope Product news in brief Luminex to increase assay speeds and efficiency Informed consent 'not up to scratch' IDT simplifies miRNA discovery with miRCat launch deltaDOT selected to aid 'the accelerated manufacture of pharmaceuticals' New test machines have the X factor Industry news in brief 'Stretching' DNA could unravel drug interactions Kinaxo to expand the reach of its proteomics platform Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals Breaking news Pharmaceutical Technology - Europe Pharmaceutical Technology - North America Drug Discovery Outsourcing Pharma Biopharmaceutical Science and Business Laboratory Equipment Access Decision News Media e-newsletters for the food, beverage & nutition industries click here

	To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com